Form 4: Ormat Director Sells Shares After SAR Exercise
Insider Transaction Report
Ormat Technologies Director Stanley Stern exercised Stock Appreciation Rights and subsequently sold a portion of his common stock holdings.
Summary
- Stanley Stern, a Director of Ormat Technologies, Inc. (ORA), reported transactions involving the company's common stock and Stock Appreciation Rights (SARs).
- On September 26, 2025, Stern exercised 1,210 SARs with an exercise price of $76.87, which were set to expire on November 6, 2025.
- The exercise resulted in a net settlement, where 981 shares were disposed of, and 229 shares were issued to Stern based on a market value of $94.83 per share.
- Concurrently, Stern sold the 229 shares received from the SAR exercise at $94.83 per share.
- On September 30, 2025, Stern sold an additional 400 shares of common stock at $95.98 per share.
- Following these transactions, Stern's direct beneficial ownership of Ormat Technologies common stock decreased from 6,471 shares to 4,861 shares.
Sentiment
Score: 6
Explanation: The exercise of expiring Stock Appreciation Rights indicates a director realizing value from their compensation, which is a positive for the individual. While subsequent share sales reduce insider ownership, the transactions appear to be a routine part of managing executive compensation and personal finances, rather than a strong signal of lack of confidence.
Positives
- Director Stanley Stern realized a gain by exercising 1,210 Stock Appreciation Rights (SARs) with an exercise price of $76.87 against a market value of $94.83 per share.
- The exercise of SARs before their expiration date of November 6, 2025, indicates prudent management of executive compensation instruments.
Negatives
- Director Stanley Stern reduced his direct beneficial ownership of Ormat Technologies common stock by a total of 629 shares (229 + 400 shares sold) following the SAR exercise.
- The total number of shares beneficially owned by Stern decreased from 6,471 to 4,861 shares.
Future Outlook
This filing does not contain any forward-looking statements or guidance.
Industry Context
This filing reports an individual insider transaction and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders: May view the reduction in director ownership as a slight negative, though the transactions are routine for executive compensation and personal financial management.
Key Dates
| Date | Description |
|---|---|
| 11/07/2020 | Date Stock Appreciation Rights became exercisable. |
| 09/26/2025 | Date of SAR exercise and initial common stock sale. |
| 09/30/2025 | Date of additional common stock sale and filing signature date. |
| 11/06/2025 | Expiration date of the exercised Stock Appreciation Rights. |
Recommendation
holdThe reported transactions are routine insider activity involving the exercise of expiring Stock Appreciation Rights and subsequent sale of a portion of the resulting shares. While the reduction in director ownership is noted, it does not fundamentally alter the investment thesis for Ormat Technologies based solely on this filing. Investors should consider these transactions as part of a broader assessment of the company's fundamentals and market conditions.
Keywords
Ormat Technologies, ORA, Stanley Stern, Insider Trading, Form 4, Stock Appreciation Rights, SARs, Director Transactions, Share Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.